Dumitrescu Gabriela, Mihai Catalina, Dranga Mihaela, Prelipcean Cristina Cijevschi
Gabriela Dumitrescu, Catalina Mihai, Mihaela Dranga, Cristina Cijevschi Prelipcean, Department of Medical Sciences, Grigore T. Popa University of Medicine and Pharmacy, Iasi 700115, Romania.
World J Gastroenterol. 2014 Mar 7;20(9):2392-6. doi: 10.3748/wjg.v20.i9.2392.
To describe the relationship between vitamin D levels and inflammatory bowel disease (IBD) characteristics in northeastern Romanian patients.
This was a prospective study of 47 consecutive IBD patients admitted to The Institute of Gastroenterology and Hepatology in Iasi, Romania between March 2011 and June 2012. The diagnosis of IBD was established based on endoscopic, histologic and radiologic findings. Demographic data, disease characteristics, ongoing treatments and biological parameters of patients (including markers of inflammation: C-reactive protein level, fibrinogen level, and erythrocyte sedimentation rate) were recorded. Serum vitamin D levels were measured and compared with age- and sex-matched healthy volunteers from the same geographic area. Vitamin D levels were defined as sufficient (> 30 ng/mL), insufficient (20-30 ng/mL), or severely deficient (< 20 ng/mL).
Thirty-three of the IBD patients included in this study had ulcerative colitis (UC) and 14 had Crohn's disease (CD). Only 24% of the UC patients and 21% of the CD patients had sufficient vitamin D levels. The vitamin D levels were significantly lower in the CD patients with moderate to severe disease activity compared to the CD patients in remission or with mild disease activity (16 ± 6 ng/mL vs 26 ± 7 ng/mL; 16 ± 6 ng/mL vs 31 ± 9 ng/mL, respectively, P < 0.05). Vitamin D levels in the UC patients were not influenced by disease activity and no correlation was observed with the inflammation markers tested (C-reactive protein, fibrinogen, and erythrocyte sedimentation rate). No association was observed between vitamin D levels and smoking status or ongoing medication (5ASA, steroids, and anti-TNFα). Newly diagnosed IBD patients had lower vitamin D levels than patients with established cases, though these differences were not significant (UC: 22 ± 9 ng/mL vs 26 ± 12 ng/mL; CD: 18 ± 6 ng/mL vs 27 ± 11 ng/mL, respectively). Although no association was found between the season during which the visit was scheduled and vitamin D levels, the UC patients assessed during the winter tended to have lower levels than those assessed during the summer (22 ± 9 ng/mL vs 28 ± 13 ng/mL, respectively).
Vitamin D levels are significantly reduced in IBD patients in northeastern Romania, with the lowest levels occurring in CD patients with moderate to severe disease activity.
描述罗马尼亚东北部炎症性肠病(IBD)患者维生素D水平与IBD特征之间的关系。
这是一项对2011年3月至2012年6月期间连续收治于罗马尼亚雅西胃肠病学和肝病研究所的47例IBD患者进行的前瞻性研究。IBD的诊断基于内镜、组织学和放射学检查结果。记录患者的人口统计学数据、疾病特征、正在进行的治疗以及生物学参数(包括炎症标志物:C反应蛋白水平、纤维蛋白原水平和红细胞沉降率)。测量血清维生素D水平,并与来自同一地理区域的年龄和性别匹配的健康志愿者进行比较。维生素D水平被定义为充足(>30 ng/mL)、不足(20 - 30 ng/mL)或严重缺乏(<20 ng/mL)。
本研究纳入的IBD患者中,33例患有溃疡性结肠炎(UC),14例患有克罗恩病(CD)。只有24%的UC患者和21%的CD患者维生素D水平充足。与处于缓解期或轻度疾病活动的CD患者相比,中度至重度疾病活动的CD患者维生素D水平显著更低(分别为16±6 ng/mL对26±7 ng/mL;16±6 ng/mL对31±9 ng/mL,P<0.05)。UC患者的维生素D水平不受疾病活动影响,且与所检测的炎症标志物(C反应蛋白、纤维蛋白原和红细胞沉降率)无相关性。维生素D水平与吸烟状况或正在使用的药物(5-氨基水杨酸、类固醇和抗TNFα)之间未观察到关联。新诊断的IBD患者维生素D水平低于确诊患者,尽管这些差异不显著(UC:22±9 ng/mL对26±12 ng/mL;CD:18±6 ng/mL对27±11 ng/mL)。虽然未发现就诊安排的季节与维生素D水平之间存在关联,但冬季评估的UC患者维生素D水平往往低于夏季评估的患者(分别为22±9 ng/mL对28±13 ng/mL)。
罗马尼亚东北部IBD患者的维生素D水平显著降低,其中最低水平出现在中度至重度疾病活动的CD患者中。